⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3225189 | 1.00 | — | — | |
| SCHEMBL207758 | 0.80 | — | — | |
| SCHEMBL208461 | 0.80 | — | — | |
| SCHEMBL11289860 | 0.78 | IDO1 (0.42) | — | |
| SCHEMBL11289858 | 0.78 | IDO1 (0.42) | — | |
| SCHEMBL11289862 | 0.78 | IDO1 (0.42) | — | |
| SCHEMBL16053133 | 0.74 | KDM4E (0.35) | — | |
| SCHEMBL6321652 | 0.69 | MAPT (0.35) | — | |
| SCHEMBL8134246 | 0.68 | — | — | |
| SCHEMBL8134253 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-1144369-B1 | ACETYLENIC ARYL SULFONAMIDE AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS | WYETH CORP (US) | 2004-07-21 | — | — | EP | claimed |
| US-6762178-B2 | FOR USE IN TREATMENT OF DISEASE CONDITIONS MEDIATED BY TNF-ALPHA, SUCH AS RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, SEPSIS, AIDS, ULCERATIVE COLITIS, MULTIPLE SCLEROSIS, CROHN'S DISEASE, DEGENERATIVE CARTILAGE LOSS | WYETH HOLDINGS CORPORATION | 2004-07-13 | — | — | US | claimed |
| US-20010056088-A1 | Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors | AMERICAN CYANAMID COMPANY (US) | 2001-12-27 | — | — | US | claimed |
| EP-1144369-A2 | ACETYLENIC ARYL SULFONAMIDE AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS | American Cyanamid Company (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000044710-A2 | ACETYLENIC ARYL SULFONAMIDE AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-08-03 | — | — | WO | claimed |
| WO-1995006468-A1 | METHOD FOR TREATING MIGRAINE HEADACHES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-03-09 | — | — | WO | claimed |
| US-4166174-A | ANALGESICS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1979-08-28 | — | — | US | claimed |
| US-3951984-A | 3-Benzazocine compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-04-20 | — | — | US | claimed |
| JP-59098059-A | — | — | None | — | — | JP | disclosed |
| JP-53009322-A | — | — | None | — | — | JP | disclosed |
| JP-10114748-A | — | — | None | — | — | JP | disclosed |
| JP-59013760-A | — | — | None | — | — | JP | disclosed |
| US-12325691-B2 | Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-06-10 | — | — | US | disclosed |
| US-4008267-A | ANALYZING | AB KABI (SW) | 1977-02-15 | — | — | US | disclosed |
| US-3951984-A | 3-Benzazocine compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-04-20 | — | — | US | disclosed |
| US-3951984-A | 3-Benzazocine compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-04-20 | — | — | US | disclosed |
| US-3951984-A | 3-Benzazocine compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-04-20 | — | — | US | disclosed |
| US-3936462-A | CNS DEPRESSANT, ANALGESIC | STERLING DRUG INC. (US) | 1976-02-03 | — | — | US | disclosed |
| US-3932422-A | ANALGESICS, NARCOTIC ANTAGONISTS | STERLING DRUG INC. (US) | 1976-01-13 | — | — | US | disclosed |